Gordon Joseph F 4

4 · Bausch Health Companies Inc. · Filed Mar 2, 2022

Form 4

Period: 2022-02-26

President Bausch & Lomb/Int'l

Transactions

Exercise/Conversion
Restricted Share Units
2022-02-27$24.35/sh−17,350$422,473→ 0 total
Exercise: $24.35Exp: 2022-02-27→ Common Shares, No Par Value (0 underlying)
Exercise/Conversion
Common Shares, No Par Value
2022-02-27+17,350→ 127,988 total
Tax Payment
Common Shares, No Par Value
2022-02-26$24.35/sh−1,522$37,061→ 120,233 total
Tax Payment
Common Shares, No Par Value
2022-02-27$24.35/sh−6,233$151,774→ 121,755 total
Tax Payment
Common Shares, No Par Value
2022-02-27$24.35/sh−1,716$41,785→ 118,517 total
Award
Restricted Share Units
2022-02-27+17,350→ 0 total
Exp: 2022-02-27→ Common Shares, No Par Value (17,350 underlying)
Sale
Common Shares, No Par Value
2022-03-01$23.82/sh−6,338$150,971→ 112,179 total

Footnotes (6)

[F1]Reflects the vesting and conversion of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person, into common shares, no par value ("Common Shares") of the Issuer.
[F2]Each PSU converts into Common Shares on a one-for-one basis
[F3]This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs.
[F4]This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units ("RSUs").
[F5]This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of RSUs.
[F6]The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2021.

Documents

1 file